{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:38:04Z","timestamp":1779223084359,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jceh.2025.103157","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:04:54Z","timestamp":1755824694000},"page":"103157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Noncirrhotic Portal Fibrosis"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-4921","authenticated-orcid":false,"given":"Sagnik","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103157_bib1","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2025.103157_bib2","first-page":"1","article-title":"Preventing the progression of cirrhosis to decompensation and death","author":"Villanueva","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.cld.2019.07.006","article-title":"Noncirrhotic portal hypertension: current and emerging perspectives","volume":"23","author":"Khanna","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s12072-024-10739-6","article-title":"Non-cirrhotic portal fibrosis\/idiopathic portal hypertension: APASL recommendations for diagnosis and management","volume":"18","author":"Shukla","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103157_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/CLD.0000000000000232","article-title":"Noncirrhotic portal hypertension\u2014Historical perspectives bring clarity to the entity and its management","volume":"23","author":"Philips","year":"2024","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00000658-194510000-00001","article-title":"The problem of portal hypertension in relation to the hepatosplenopathies","volume":"122","author":"Whipple","year":"1945","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2025.103157_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-66-1-41","article-title":"Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction","volume":"66","author":"Boyer","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2025.103157_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension \u2013 diagnosis and management","volume":"60","author":"Khanna","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/MPG.0b013e31817b6eea","article-title":"Aetiology and management of extrahepatic portal vein obstruction in children: king's college hospital experience","volume":"47","author":"Abd El-hamid","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2025.103157_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1078\/0344-0338-5710012","article-title":"Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver","volume":"197","author":"Nakanuma","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jceh.2025.103157_bib11","first-page":"1130","article-title":"Familial aggregation in noncirrhotic portal fibrosis: a report of four families","volume":"82","author":"Sarin","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103157_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12664-023-01454-5","article-title":"Focused panel sequencing points to genetic predisposition in non-cirrhotic intrahepatic portal hypertension patients in India","volume":"43","author":"Aaron","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103157_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0016-5085(88)90255-7","article-title":"Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits","volume":"94","author":"Kono","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103157_bib14","first-page":"417","article-title":"A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein","volume":"3","author":"Omanwar","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT"},{"key":"10.1016\/j.jceh.2025.103157_bib15","first-page":"147","article-title":"Hepatic fibrogenesis using chronic arsenic ingestion: studies in a murine model","volume":"37","author":"Sarin","year":"1999","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.jceh.2025.103157_bib16","first-page":"485","article-title":"Splenomegaly and immune complex splenitis in rabbits with experimentally induced chronic serum sickness: immunopathological findings","volume":"34","author":"Albini","year":"1983","journal-title":"J Reticuloendothel Soc"},{"key":"10.1016\/j.jceh.2025.103157_bib17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1440-1746.2002.02882.x","article-title":"Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract","volume":"17","author":"Kathayat","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib18","first-page":"333","article-title":"Hepatosplenic lesions induced by experimental Schistosoma malayensis in rabbits","volume":"24","author":"Shekhar","year":"1993","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"10.1016\/j.jceh.2025.103157_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103157_bib20","first-page":"145","article-title":"Role of endothelial-mesenchymal transition in idiopathic portal hypertension","volume":"28","author":"Sato","year":"2013","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jceh.2025.103157_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1440-1746.2002.02596.x","article-title":"Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature","volume":"17","author":"Dhiman","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib22","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103157_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.dld.2018.01.132","article-title":"Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis","volume":"50","author":"Gioia","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1022549018807","article-title":"Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients","volume":"48","author":"Kaymakoglu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2025.103157_bib25","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","article-title":"Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study","volume":"35","author":"Schouten","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103157_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13023-015-0288-8","article-title":"Idiopathic non-cirrhotic portal hypertension: a review","volume":"10","author":"Schouten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"Senzolo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MPG.0000000000001485","article-title":"Noncirrhotic portal fibrosis in pediatric population","volume":"64","author":"Sood","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2025.103157_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12072-019-09979-8","article-title":"Pediatric non-cirrhotic portal fibrosis: role of endoscopic management in determining long-term outcome","volume":"14","author":"Prasad","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103157_bib31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4254\/wjh.v13.i10.1269","article-title":"Pediatric non-cirrhotic portal hypertension: endoscopic outcome and perspectives from developing nations","volume":"13","author":"Sarma","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11901-023-00613-8","article-title":"Shalimar. Nodular regenerative hyperplasia","volume":"22","author":"Abbey","year":"2023","journal-title":"Curr Hepat Rep"},{"issue":"suppl ment","key":"10.1016\/j.jceh.2025.103157_bib33","first-page":"S127","article-title":"Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction","volume":"64","author":"Vallonthaiel","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.jceh.2025.103157_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/his.12114","article-title":"Histological features in western patients with idiopathic non-cirrhotic portal hypertension","volume":"62","author":"Verheij","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.jceh.2025.103157_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cld.497","article-title":"Noncirrhotic portal hypertension: an overview","volume":"6","author":"Etzion","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/his.13738","article-title":"Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition","volume":"74","author":"Guido","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.jceh.2025.103157_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00428-018-2340-2","article-title":"Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al","volume":"473","author":"Hytiroglou","year":"2018","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.jceh.2025.103157_bib38","first-page":"592","article-title":"Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria","volume":"34","author":"Liang","year":"2021","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.jceh.2025.103157_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cld.459","article-title":"Noncirrhotic portal hypertension: pathology and nomenclature","volume":"5","author":"Kleiner","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103157_bib41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s12072-010-9246-7","article-title":"Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients","volume":"5","author":"Saigal","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103157_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2010.07.038","article-title":"Obliterative portal venopathy: portal hypertension is not always present at diagnosis","volume":"54","author":"Cazals-Hatem","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2024.07.035","article-title":"Porto-sinusoidal vascular liver disorder with portal hypertension: natural history and long-term outcome","volume":"82","author":"Magaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.dld.2024.10.025","article-title":"Porto-sinusoidal vascular disorder with known etiologies had more severe portal hypertension and poorer outcomes","volume":"57","author":"Ma","year":"2025","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib46","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00535-012-0703-z","article-title":"Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography","volume":"48","author":"Furuichi","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103157_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12072-024-10713-2","article-title":"Role of splenic hepatic elastography ratio in differentiating non-cirrhotic portal fibrosis and chronic liver disease in children and adolescents","volume":"19","author":"Upadhyay","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103157_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dld.2022.09.018","article-title":"Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension","volume":"55","author":"Ferreira-Silva","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2025.103157_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jceh.2017.03.002","article-title":"Transient elastography (Fibroscan) in patients with non-cirrhotic portal fibrosis","volume":"7","author":"Sharma","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib50","first-page":"855","article-title":"Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension","volume":"44","author":"Seijo","year":"2012","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jceh.2025.103157_bib51","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103157_bib52","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103157_bib53","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2025.103157_bib54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/lt.20431","article-title":"Liver transplantation for severe intrahepatic noncirrhotic portal hypertension","volume":"11","author":"Krasinskas","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2025.103157_bib55","first-page":"239","article-title":"Prophylactic surgery in non-cirrhotic portal fibrosis:is it worthwhile?","volume":"24","author":"Pal","year":"2005","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103157_bib56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14701\/ahbps.2020.24.2.168","article-title":"Splenectomy with endotherapy in non-cirrhotic portal fibrosis related portal hypertension: can it be an alternative to proximal spleno-renal shunt?","volume":"24","author":"Saluja","year":"2020","journal-title":"Ann Hepato-Biliary-Pancreat Surg"},{"key":"10.1016\/j.jceh.2025.103157_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103157_bib58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2214\/AJR.15.14637","article-title":"An overview of splenic embolization","volume":"205","author":"Ahuja","year":"2015","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jceh.2025.103157_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101435","article-title":"Partial splenic artery embolization for the management of symptomatic hypersplenism in portal hypertension: clinical insights from a case series","volume":"14","author":"Satai","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103157_bib61","first-page":"694","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2025.103157_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12072-007-9010-9","article-title":"Noncirrhotic portal fibrosis\/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment","volume":"1","author":"Sarin","year":"2007","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103157_bib63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/ijmr.IJMR_1405_17","article-title":"What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors","volume":"149","author":"Goel","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2025.103157_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1746.2002.02660.x","article-title":"Non-cirrhotic portal hypertension: why is it so common in India?","volume":"17","author":"Okuda","year":"2002","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:13:45Z","timestamp":1763399625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325006577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0973688325006577"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103157","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noncirrhotic Portal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103157"}}